Table 1. Demographic, laboratory characteristics of patients with KD during diagnosis in the IVIG-responsive and IVIG-resistant groups.
| IVIG responsive | IVIG resistant | p value | ||
|---|---|---|---|---|
| Sex | Male | 2,416 (52.2) | 317 (60.5) | <0.001 |
| Female | 1,827 (39.5) | 181 (34.5) | ||
| Not identified | 384 (8.3) | 26 (5.0) | ||
| Age (months) | 32.20±24.22 | 33.04±23.68 | 0.447 | |
| Duration of fever before IVIG treatment | 6.56±3.84 | 6.86±3.53 | 0.088 | |
| PMN (%) | 62.38±32.94 | 70.89±15.75 | <0.001 | |
| Albumin (g/dL) | 4.17±8.94 | 3.75±0.52 | 0.287 | |
| Total bilirubin (g/dL) | 0.78±5.55 | 1.23±1.55 | 0.068 | |
| AST (IU/L) | 76.08±136.73 | 140.83±228.48 | <0.001 | |
| ALT (IU/L) | 84.50±136.22 | 153.14±209.55 | <0.001 | |
| CRP (mg/dL) | 7.81±10.15 | 10.32±8.74 | <0.001 | |
| NT-proBNP (pg/dL) | 940.62±2,326.10 | 1,573.91±3,166.46 | <0.001 | |
Values are presented as number (%) or mean±standard deviation.
ALT = alanine aminotransferase; AST = aspartate aminotransferase; CRP = C-reactive protein; IVIG = intravenous immunoglobulin; KD = Kawasaki disease; NT-proBNP = N-terminal-pro-brain natriuretic peptide; PMN = polymorphonuclear neutrophil.